C2i Genomics
Product strategy + product naming + verbal expression + product logos + creative concept + booth design + flyers
Cloud-based cancer genomics
C2i Genomics engaged Audacity in the early stages of their start-up. They sought creative and strategic support in launching the first whole-genome, ultra-sensitive, personalized cancer monitoring platform. This cloud-based technology enables scalable processing of cancer genomics data, democratizing access to high-precision cancer monitoring, anywhere in the world.
strategy
creative
research
from start-up to global impact
Audacity leveraged previously established branding and messaging from C2i Genomics as inspiration to further develop product-level verbal expression, naming, and logo design. Strategic messaging and visuals were then leveraged in a creative concept, flyers and booth design to build awareness. And they certainly garnered interest: Shortly after, C2i Genomics was successfully acquired by Veracyte, a global diagnostics company.
expanding on C2i: the command/cancer control index
C2i Genomics needed names and logos for two products they were launching: 1) Their cloud-based tumor burden monitoring platform and 2) Their ultra-sensitive Minimal Residual Disease (MRD) assay. Unifying both platform and test under one brand and inspired by the C2i corporate name, we landed on C2intelligence and C2inform.
a pioneering platform
Combining cutting-edge genomics and AI, C2i Genomics provides the world’s first whole-genome cancer intelligence platform. This transformative approach needed an equally pioneering concept to convey its impact on the cancer care landscape: One small operational step. One giant leap for your lab capabilities.
bringing C2i to the world
To drive awareness for C2i Genomics’ corporate and product brands, Audacity designed a 20’x20’ trade show booth landscape.
